4.5 Review

Impulse control disorders in Parkinson's disease patients treated with pramipexole and ropinirole: a systematic review and meta-analysis

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Dopamine D1 Agonists: First Potential Treatment for Late-Stage Parkinson's Disease

Mechelle M. Lewis et al.

Summary: Current pharmacotherapy has limited efficacy and intolerable side effects in late-stage Parkinson's disease patients. A study was conducted to explore the efficacy of a D-1/5 dopamine agonist in these patients. Caregiver assessment was used as the primary efficacy measure, and the results showed that the D-1/5 agonist had better efficacy compared to levodopa in most patients.

BIOMOLECULES (2023)

Review Clinical Neurology

Efficacy of pramipexole on quality of life in patients with Parkinson's disease: a systematic review and meta-analysis

Tao Li et al.

Summary: Parkinson's disease is a chronic, progressive nervous system disorder with no known cure. This meta-analysis found that pramipexole may have the potential to improve the quality of life in patients with Parkinson's disease.

BMC NEUROLOGY (2022)

Review Cell Biology

Dopamine: Functions, Signaling, and Association with Neurological Diseases

Marianne O. Klein et al.

CELLULAR AND MOLECULAR NEUROBIOLOGY (2019)

Review Public, Environmental & Occupational Health

Dopamine Agonists and Impulse Control Disorders: A Complex Association

Marie Grall-Bronnec et al.

DRUG SAFETY (2018)

Article Pharmacology & Pharmacy

Rotigotine is a potent agonist at dopamine D1 receptors as well as at dopamine D2 and D3 receptors

Martyn Wood et al.

BRITISH JOURNAL OF PHARMACOLOGY (2015)

Review Clinical Neurology

Clinical Spectrum of Impulse Control Disorders in Parkinson's Disease

Daniel Weintraub et al.

MOVEMENT DISORDERS (2015)

Article Clinical Neurology

Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study

Pedro J. Garcia-Ruiz et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)

Review Clinical Neurology

Motor and nonmotor complications in Parkinson's disease: an argument for continuous drug delivery?

K. Ray Chaudhuri et al.

JOURNAL OF NEURAL TRANSMISSION (2013)

Article Clinical Neurology

Pramipexole in patients with early Parkinson's disease (PROUD): a randomised delayed-start trial

Anthony H. V. Schapira et al.

LANCET NEUROLOGY (2013)

Article Medicine, General & Internal

Frequency of New-Onset Pathologic Compulsive Gambling or Hypersexuality After Drug Treatment of Idiopathic Parkinson Disease

J. Michael Bostwick et al.

MAYO CLINIC PROCEEDINGS (2012)

Review Clinical Neurology

Systematic Review of Levodopa Dose Equivalency Reporting in Parkinson's Disease

Claire L. Tomlinson et al.

MOVEMENT DISORDERS (2010)

Review Neurosciences

Affective neuroscience of pleasure: reward in humans and animals

Kent C. Berridge et al.

PSYCHOPHARMACOLOGY (2008)

Article Clinical Neurology

Continuous dopaminergic stimulation - From theory to clinical practice

Angelo Antonini

PARKINSONISM & RELATED DISORDERS (2007)